Five Foreign Stocks To Buy Now

Investors with Long Positions (as of June 30): 151

Aggregate Value of Investors’ Holdings (as of June 30): $20.73 Billion 

The $99.24 billion Dublin-based manufacturer and distributor of biosimilars and over-the-counter pharmaceutical products has operations in more than 100 countries. Hedge fund’s total holdings in Allergan PLC (NYSE:AGN) amounted at 17.4% of its common shares at the end of June. However, the total number of hedgies holding the company in their portfolios dipped by six during the second quarter, with the value of their holdings sliding by $1.24 billion. John Paulson‘s Paulson & Co is the largest stockholder of Allergan PLC (NYSE:AGN) among the investors that we track, as it raised its stake in the company by 28% during the April-June quarter to 7.17 million shares valued at $2.18 billion. Following the sale of its generics unit to Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA), Allergan recently raised its financial projections for the second half of the year, increasing its expected branded revenue by 10%.

Disclosure: None